Gamma Investing LLC Blueprint Medicines Corp Transaction History
Gamma Investing LLC
- $1.01 Trillion
- Q3 2024
A detailed history of Gamma Investing LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Gamma Investing LLC holds 187 shares of BPMC stock, worth $17,606. This represents 0.0% of its overall portfolio holdings.
Number of Shares
187
Previous 186
0.54%
Holding current value
$17,606
Previous $20 Million
13.71%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BPMC
# of Institutions
350Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$629 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$626 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$507 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$373 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$260 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.62B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...